RxDoctor Payments Data

Erich Weidenbener, MD

Sports Medicine · Bloomington, INNPI 1811049380

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $378 and has fallen 76.1% since, to $90 in 2025.

$1,368in general payments, 2019–2025

Across 68 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avanos Medical$310
  • Amgen$224
  • Zyla Life Sciences, Inc.$130
  • Bioventus LLC$112
  • Stryker$101
  • Johnson & Johnson$84
  • plus $407 from 9 others

What the payments were for

  • Food & beverage$1,368100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,368 in reported general payments places this provider in the 65th percentile of 156 sports medicine providers in Indiana.

See all sports medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$187,190
Medicare patients
686
Services billed
8,664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib78$2,351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen166$1,996
Meloxicam672$1,995
Diclofenac Sodium31$728
Tramadol Hcl110$327
Prednisone90$302
Gabapentin31$224
Cyclobenzaprine Hcl20$147
Alendronate Sodium12$9

Paid to pharmacies, not to this prescriber.

Other sports medicine in Bloomington

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →